logo
  

EARNINGS SUMMARY: Details of Nektar Therapeutics Q1 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$122.97 million in Q1 vs. -$138.65 million in the same period last year.
-EPS: -$0.68 in Q1 vs. -$0.78 in the same period last year.
-Analysts projected -$0.72 per share
-Revenue: $23.65 million in Q1 vs. $50.57 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT